510(k) · Cleared
Recalled · Class II · 2021Access hsTnl
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Beckman Coulter, Inc. · MMI Immunoassay Method, Troponin Subunit
Cleared on Jun 14, 2018 as substantially equivalent to K121214 (Beckman Coulter, Inc., 2013) after a 272-day review. Its family tree reaches back 2 generations to 1992. 4 later devices descend from it. It has been recalled once.
- Decided
- Jun 14, 2018
- Review
- 272 days
- Class
- Class II
- Product code
- MMI
- Recalls
- 1
- Predicates
- 1
Its longest line of descent runs back 2 generations to K922823 (1992). 3 ancestors in all. 4 later devices descend from it, 2 citing it directly.
- Root · 2 generations backK922823 Access Theophylline Immunoassay ReagentsBio-Rad Laboratories, Inc. · 1992 · Recalled
- 1 generation backK121214 Access Accutni+3 Reagent and Access ACCUTN1+3 Calibrators for Use on…Beckman Coulter, Inc. · 2013 · Recalled
- This deviceK172787 Access hsTnlBeckman Coulter, Inc. · 2018
- Descendant · cites it directly · 2 of its ownK230648 Access hsTnIBeckman Coulter, Inc. · 2023 · Recalled
- Descendant · 2 generations on · 0 of its ownK243483 Access hsTnIBeckman Coulter, Inc. · 2025
- Descendant · 2 generations on · 0 of its ownK242870 Access hsTnIBeckman Coulter, Inc. · 2025
- Descendant · cites it directly · 0 of its ownK222881 Access hsTnIBeckman Coulter, Inc. · 2023 · Recalled
Most influential descendants
Showing 4 of 4 · See all- K230648Access hsTnIBeckman Coulter, Inc. · 2023 · cites it directly2descendants
- K243483Access hsTnIBeckman Coulter, Inc. · 2025 · 2 generations on0descendants
- K242870Access hsTnIBeckman Coulter, Inc. · 2025 · 2 generations on0descendants
- K222881Access hsTnIBeckman Coulter, Inc. · 2023 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K922823 | Access Theophylline Immunoassay Reagents | Bio-Rad Laboratories, Inc. | 1992 | 19 |
| −1 | K121214 | Access Accutni+3 Reagent and Access ACCUTN1+3 Calibrators for Use on the… | Beckman Coulter, Inc. | 2013 | 5 |
| 0 (this device) | K172787 | Access hsTnl | Beckman Coulter, Inc. | 2018 | — |
| +1 | K230648 | Access hsTnI | Beckman Coulter, Inc. | 2023 | 1 |
| +2 | K243483 | Access hsTnI | Beckman Coulter, Inc. | 2025 | — |
| +2 | K242870 | Access hsTnI | Beckman Coulter, Inc. | 2025 | — |
| +1 | K222881 | Access hsTnI | Beckman Coulter, Inc. | 2023 | 1 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2005 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2023 | 2 | 0 |
| 2025 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MMI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MMI device
- #1 K253051 i-STAT hs-TnI cartridge with the i-STAT…score 13.0 · 6 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K121214 | Access Accutni+3 Reagent and Access ACCUTN1+3 Calibrators for Use on the Access 2…Summary page 5…ation Product Code: MMI Predicate Devices: The Access hsTnI claims substantial equivalence to the Access AccuTnI+3 Reagent, FDA 510(k) Number K121214, cleared June 14, 2013. Device Description: The Access hsTnI and the Access 2 Immunoassay System compose the A… | 2013 |
What descends from it? (4)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Aug 9, 2021 | Class II | Z-0032-2022 | Unknown/Undetermined by firm | Through customer feedback, testing a sample with cardiac troponin I concentration that are >270,000 pg/mL may cause carryover into the hsTnl reagent pack. The carryover is caused by sample-to-pack carryover predominantly into the particle… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 26 years and passes through 2 companies; a new generation was cleared every 20.9 years on median.
- 3 of the 3 ancestors have a recall of any class.
- Of its descendants, K230648 (Beckman Coulter, Inc., 2023) has gone furthest, with 2 descendants of its own.
- 3 other devices also cite its predicate K121214.
How does its category compare?
All MMI devicesMMI Immunoassay Method, Troponin Subunit: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.
FDA decisions per year · MMI
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MMI
266in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MMI
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MMI
805in 2025
MAUDE reports naming product code MMI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 190 | 6 | 352 |
| 2008 | 1 | — | 2 | 837 |
| 2009 | 1 | — | 3 | 1,010 |
| 2010 | 2 | — | 5 | 1,335 |
| 2011 | 1 | — | 1 | 2,406 |
| 2012 | 0 | — | 6 | 1,841 |
| 2013 | 2 | — | 0 | 1,394 |
| 2014 | 0 | — | 1 | 1,150 |
| 2015 | 0 | — | 1 | 831 |
| 2016 | 0 | — | 0 | 487 |
| 2017 | 1 | — | 0 | 618 |
| 2018 | 4 | 344 | 0 | 487 |
| 2019 | 3 | 88 | 1 | 521 |
| 2020 | 0 | — | 1 | 387 |
| 2021 | 1 | — | 1 | 356 |
| 2022 | 1 | — | 0 | 507 |
| 2023 | 3 | 270 | 0 | 748 |
| 2024 | 2 | — | 1 | 921 |
| 2025 | 4 | 266 | 0 | 805 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
Access hsTnI is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of cardiac troponin I (cTnI) levels in human serum and plasma using the Access 2 Immuoassay Systems to aid in the diagnosis of myocardial infarction (MI).
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K172787 · printed Nov 6, 2026
Cite this page
510(k) Report. “K172787: Access hsTnl.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K172787
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026